Work

High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma

Year: 2011

Type: article

Abstract: There are approximately 8500 new diagnoses of Hodgkin lymphoma (HL) each year in the United States [1]. Patients who do not respond to initial therapy or who relapse after initial response are rare...

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.3109/10428194.2011.572324

Authors: Andrew A. Lane, Steven L. Mcafee, Joanne Kennedy, Christine Dube, Eyal C. Attar, Karen K. Ballen, Bimalangshu R. Dey, Thomas R. Spitzer, Yi-Bin Chen

Institutions: Harvard University, Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: G1547207268

OpenAlex ID: W2082000367

FWCI: 0.601

Cites: 14

Cited by: 9

Related to: 10